Project Details
| Status | Active |
|---|---|
| Effective start/end date | 04/16/26 → 12/16/26 |
Funding
- Krystal Biotech Incorporated: $1.00
A Phase 1/2, Multicenter, Double-Masked, Placebo-Controlled Study of KB801 in Subjects with Stage 2 or 3 Neurotrophic Keratitis
- Honkanen, Robert (PI)
- Boyle, Nariman (CoPI)
- Gorgani, Farzan (CoPI)
- Siu, Nga Yan (CoPI)
- Urmaza, Benedict (CoPI)
- Weissbart, Sarah (CoPI)
Project: Research